MHRA guidance on its assessment of non-clinical data generated outside OECD system 

Imported from official source

Alert

Safety Classified by Officially

The MHRA has today, 4th October 2026, published guidance explaining its patient-centred approach to clinical trial applications that rely on non-clinical safety data generated outside the Organisation for Economic Co-operation and Development (OECD) Mutual Acceptance of Data framework.  

The approach will help support a further risk-proportionate approach to clinical research, helping advance the development of new treatments and increase opportunities for UK patients to take part in trials.  

The OECD Mutual Acceptance of Data system provides an internationally recognised approach for generating non-clinical safety data, in line with agreed standards for testing and Good Laboratory Practice. Data generated within the framework remain the expected basis for UK clinical trial applications. 

The new guidance explains how the MHRA may consider non-clinical data generated outside the OECD framework in individual clinical trial applications where the available evidence and circumstances of the intended patient population support further regulatory consideration. It provides greater clarity for developers while maintaining standards for participant safety, scientific rigour and data integrity.  

Under this approach, the MHRA will consider the available non-clinical evidence alongside the circumstances of the proposed trial. This includes the participant population, the seriousness of the condition, unmet medical need and the stage and design of the trial.  

Accordingly, in limited circumstances, the MHRA may consider an enhanced non-clinical assessment, including for first-in-human trials in patients with advanced cancers or other serious or life-threatening conditions where there is significant unmet medical need. This provides additional scientific scrutiny of the available evidence where appropriate.  

This is an extract. The publication continues at the source.

Contains public sector information licensed under the Open Government Licence v3.0. Licence

Read the original at the source: https://www.gov.uk/government/news/mhra-guidance-on-its-assessment-of-non-clinical-data-generated-outside-oecd-system

Officially imported this from Medicines and Healthcare products Regulatory Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
Medicines and Healthcare products Regulatory Agency — imported from official source
Official source
https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency.atom ATOM
Imported
November 04, 2026 16:00
Versions
1 recorded
Identity
https://www.gov.uk/government/news/mhra-guidance-on-its-assessment-of-non-clinical-data...

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.